Twilio R&D increased by 0.8% to $262.17M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.1%, from $254.30M to $262.17M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 6.6% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $181.28M | $209.89M | $223.25M | $240.61M | $279.64M | $284.74M | $274.09M | $238.60M | $226.90M | $241.65M | $235.65M | $260.46M | $242.79M | $261.51M | $243.99M | $254.30M | $243.50M | $262.31M | $260.06M | $262.17M |
| QoQ Change | — | +15.8% | +6.4% | +7.8% | +16.2% | +1.8% | -3.7% | -13.0% | -4.9% | +6.5% | -2.5% | +10.5% | -6.8% | +7.7% | -6.7% | +4.2% | -4.2% | +7.7% | -0.9% | +0.8% |
| YoY Change | — | — | — | — | +54.3% | +35.7% | +22.8% | -0.8% | -18.9% | -15.1% | -14.0% | +9.2% | +7.0% | +8.2% | +3.5% | -2.4% | +0.3% | +0.3% | +6.6% | +3.1% |